Clinical Trial Update: OPPOSITE: Outcome Prediction of Systemic Treatment in Esophagogastric Carcinoma [NA]

View source ↗

Summary

Clinical trial OPPOSITE, studying outcome prediction of systemic treatment in esophagogastric carcinoma, has completed. The sponsor is University Hospital Heide…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Esophageal Adenocarcinoma
• Esophageal Cancer
• Gastric Adenocarcinoma
• Gastric Cancer
• Gastroesophageal Junction Adenocarcinoma
• Gastroesophageal Junction Cancer

Snippet

Sponsor: University Hospital Heidelberg | Conditions: Gastric Neoplasm, Gastroesophageal Junction Adenocarcinoma | NA | Status: COMPLETED